Agilent Technologies to Acquire BIOVECTRA Inc.
July 22, 2024
We are thrilled to announce that Agilent Technologies, Inc. has agreed to acquire BIOVECTRA Inc. from H.I.G. Capital. This acquisition represents a significant milestone in our journey, bringing new opportunities to enhance patient care by broadening our capabilities for our global pharmaceutical partners.
What This Means for You:
- No Immediate Changes: Your current projects and contacts at BIOVECTRA will remain unchanged.
- Consistent Service: Continue to expect the same high level of service you have always received from us.
We understand you might have questions. Please feel free to reach out to us using this form. We will keep you updated with any new information as it becomes available.
Thank you for your ongoing trust and partnership. We are confident that this acquisition will allow us to better support your needs.
|
Reach out to us with your questions using the form below.
|
